RxDoctor Payments Data

Barton Blackorby, MD

Retina Specialist · Brentwood, MONPI 1477825875

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Genentech USA, Inc. accounts for 79.8% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $22,101, more than ten times the $744 reported in 2019.

$31,310in general payments, 2019–2025

Across 119 payments — averaging $263.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$25K
  • Bausch & Lomb Americas Inc.$2K
  • Dutch Ophthalmic, USA$1K
  • AbbVie$629
  • Regeneron Healthcare Solutions, Inc.$612
  • Astellas Pharma US Inc$443
  • plus $2K from 11 others

What the payments were for

  • Consulting fees$3,11010%
  • Speaking & faculty fees$18,62059%
  • Grants$2,0006%
  • Travel & lodging$2,6338%
  • Food & beverage$4,94616%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,310 in reported general payments places this provider in the 85th percentile of 45 retina specialist providers in Missouri.

See all retina specialist providers in Missouri

Medicare billing

Part B allowed, 2024
$1,789,308
Medicare patients
768
Services billed
28,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate213$7,704
Ketorolac Tromethamine104$2,212
Brimonidine Tartrate63$1,738
MoxifloxacinMoxifloxacin Hcl38$892
Ofloxacin51$564
Latanoprost20$264
Dorzolamide Hcl12$231
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat17$186
Timolol Maleate11$91

Paid to pharmacies, not to this prescriber.

Other retina specialist in Brentwood

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →